Management of Chronic Myeloid Leukemia i
โ
Meinolf Suttorp; Louise Eckardt; Josephine Tabea Tauer; Frederic Millot
๐
Article
๐
2012
๐
Current Science Inc.
๐
English
โ 203 KB
Childhood chronic myelogenous leukemia (CML) is a rare malignancy, and experience with optimal treatment is very limited. Traditionally, allogeneic hematopoietic stem cell transplantation was considered the only curative treatment. Imatinib, a small-molecule inhibitor of the BCR-ABL tyrosine kinase